Topic: Cancer treatment
Alongside a clinical trial of ribociclib for prostate cancer, Professor Butler and her team will identify biomarkers that can be used to identify which patients this new drug is likely to benefit.
Researchers will test a more targeted treatment approach in greatly improving outcomes for individual children with advanced neuroblastoma.
Researchers will use cutting-edge imaging technology and lab models that mimic pancreatic cancer and watch tumour response to treatment.
Dr Jeremy Booth and his team will use tracking technology during radiation treatment for prostate, liver and pancreas cancer patients.
Dr Tiffen hopes their research will deepen our understanding of the epigenetics of melanoma, as well as identifying potential new treatment approaches to improve outcomes for patients with advanced melanoma.
Researchers will investigate a new treatment approach that combines a new drug delivery method capable of specifically targeting the liver.
Researchers will look into a new molecule called ERAG, which is often present in high levels in bowel cancer cells.
Researchers will test a dual treatment approach that targets collagen production in pancreatic cancer tumours.
Researchers will develop a new website that assesses symptoms of cancer survivors and recommends care based on how severe the symptoms are
Researchers will explore the role and function of a different group of immune cells called innate lymphoid cells in treating melanoma.